| Title : FAP-Inhibitor Homodimers with Engineered Linker-Spacer Units: Toward Optimized Radiopharmaceuticals - Kumar_2026_ACS.Omega_11_49001 |
| Author(s) : Kumar N , Martin M , Bilinska A , Menendez E , De Meester I , Roesch F , Rominger A , Gourni E |
| Ref : ACS Omega , 11 :49001 , 2026 |
| Abstract : |
| PubMedSearch : Kumar_2026_ACS.Omega_11_49001 |
| PubMedID: 42662658 |
| Title : Preclinical evaluation of DOTAGA.Glu.(FAPI)(2) and DO3A.Glu.(FAPI)(2) as theranostics with human dosimetry extrapolation to lutetium-177 and terbium-161 analogs - Bilinska_2026_Eur.J.Nucl.Med.Mol.Imaging_53_1887 |
| Author(s) : Bilinska A , Kumar N , Gnesin S , Lappchen T , Menendez E , Martin M , Rosch F , Rominger A , Gourni E |
| Ref : Eur J Nucl Med Mol Imaging , 53 :1887 , 2026 |
| Abstract : |
| PubMedSearch : Bilinska_2026_Eur.J.Nucl.Med.Mol.Imaging_53_1887 |
| PubMedID: 41105225 |
| Title : Tailoring Fibroblast-Activation Protein Targeting for Theranostics: A Comparative Preclinical Evaluation of the (68)Ga- and (177)Lu-Labeled Monomeric and Dimeric Fibroblast-Activation Protein Inhibitors DOTA.SA.FAPi and DOTAGA.(SA.FAPi)(2) - Lappchen_2024_Molecules_29_ |
| Author(s) : Lappchen T , Bilinska A , Pilatis E , Menendez E , Imlimthan S , Moon ES , Afshar-Oromieh A , Rosch F , Rominger A , Gourni E |
| Ref : Molecules , 29 : , 2024 |
| Abstract : |
| PubMedSearch : Lappchen_2024_Molecules_29_ |
| PubMedID: 38999044 |